Pain Management

---

 BIOPTRON® Hyperlight decreases the production of pro-inflammatory cytokines, such as TNF-α, and increases anti-inflammatory cytokines, such as TGF –β and IL-10, in the irradiated region, reducing locally the inflammation of the affected epithelium (Falus et al., 2011, Zhevago, 2006). These cytokines are also implicated in the processes of chronic inflammation and reinforcement of defence mechanisms. With BIOPTRON® Hyperlight, the immune system is reinforced to fight more effectively against external pathogens or inflammatory agents. 

 BIOPTRON® Hyperlight increases the blood flow in irradiated capillaries, boosting the oxygen and nutrients supply, as well as the uptake of nocive substances produced by inflamed cells. This effect promotes the healing process and also decreases the ischemic pain caused by poor microcirculation (Samoilova et al., 2008). 

 BIOPTRON® Hyperlight Therapy reduces pain by stimulating the production of nitric oxide, which decreases the over-stimulation of somatic peripheral nerves and increases vasodilatation, diminishing in parallel the ischemic pain (Gaspariyan et al., 2005; Samoilova et al., 2008). 

 BIOPTRON® Hyperlight increases the production of endogen collagen and elastin, providing to the soft tissues the structure and stability necessary to recover their tensile strength. BIOPTRON® Hyperlight therapy fosters the recovery of tissues to a healthy and functional state (De Melo et al., 2016).